Nimodipine Sustained Release Tablets Market, Global Outlook and Forecast 2023-2029

Report ID: MMG34921 | Category: Pharma & Healthcare | Pages: 77 | Format: PDF | Published Date: February 21,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Nimodipine sustained-release tablets are calcium antagonists, used for cerebral vasospasm and sudden deafness caused by ischemic cerebrovascular disease, migraine, mild subarachnoid hemorrhage. It can reduce the pain of vascular, tension, cluster and mixed headaches, reduce the frequency of attacks, and prevent the appearance of aura symptoms.
This report aims to provide a comprehensive presentation of the global market for Nimodipine Sustained Release Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nimodipine Sustained Release Tablets. This report contains market size and forecasts of Nimodipine Sustained Release Tablets in global, including the following market information:
Global Nimodipine Sustained Release Tablets Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Nimodipine Sustained Release Tablets Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Nimodipine Sustained Release Tablets companies in 2022 (%)
The global Nimodipine Sustained Release Tablets market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
30mg/Piece Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Nimodipine Sustained Release Tablets include Bionpharma, Arbor Pharmaceuticals, Sofgen Pharmaceuticals, Pharmaceutics International, Heritage Pharmaceuticals, Bayer Vital, Wuhan HITECK Biopharmaceutical, Qilu Pharmaceutical and Yabao Pharmaceutical Group, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nimodipine Sustained Release Tablets manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nimodipine Sustained Release Tablets Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Nimodipine Sustained Release Tablets Market Segment Percentages, by Type, 2022 (%)
    30mg/Piece
    60mg/Piece
    Others
Global Nimodipine Sustained Release Tablets Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Nimodipine Sustained Release Tablets Market Segment Percentages, by Application, 2022 (%)
    Hospital
    Pharmacy
    Others
Global Nimodipine Sustained Release Tablets Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Nimodipine Sustained Release Tablets Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nimodipine Sustained Release Tablets revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Nimodipine Sustained Release Tablets revenues share in global market, 2022 (%)
Key companies Nimodipine Sustained Release Tablets sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Nimodipine Sustained Release Tablets sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Bionpharma
    Arbor Pharmaceuticals
    Sofgen Pharmaceuticals
    Pharmaceutics International
    Heritage Pharmaceuticals
    Bayer Vital
    Wuhan HITECK Biopharmaceutical
    Qilu Pharmaceutical
    Yabao Pharmaceutical Group
    Sihuan Pharmaceutical
    Jiangsu Kanion Pharmaceutical
    Shandong Yunmen Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nimodipine Sustained Release Tablets, market overview.
Chapter 2: Global Nimodipine Sustained Release Tablets market size in revenue and volume.
Chapter 3: Detailed analysis of Nimodipine Sustained Release Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nimodipine Sustained Release Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Nimodipine Sustained Release Tablets capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Nimodipine Sustained Release Tablets Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Nimodipine Sustained Release Tablets Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Nimodipine Sustained Release Tablets Overall Market Size
    2.1 Global Nimodipine Sustained Release Tablets Market Size: 2022 VS 2029
    2.2 Global Nimodipine Sustained Release Tablets Revenue, Prospects & Forecasts: 2018-2029
    2.3 Global Nimodipine Sustained Release Tablets Sales: 2018-2029
3 Company Landscape
    3.1 Top Nimodipine Sustained Release Tablets Players in Global Market
    3.2 Top Global Nimodipine Sustained Release Tablets Companies Ranked by Revenue
    3.3 Global Nimodipine Sustained Release Tablets Revenue by Companies
    3.4 Global Nimodipine Sustained Release Tablets Sales by Companies
    3.5 Global Nimodipine Sustained Release Tablets Price by Manufacturer (2018-2023)
    3.6 Top 3 and Top 5 Nimodipine Sustained Release Tablets Companies in Global Market, by Revenue in 2022
    3.7 Global Manufacturers Nimodipine Sustained Release Tablets Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Nimodipine Sustained Release Tablets Players in Global Market
        3.8.1 List of Global Tier 1 Nimodipine Sustained Release Tablets Companies
        3.8.2 List of Global Tier 2 and Tier 3 Nimodipine Sustained Release Tablets Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Nimodipine Sustained Release Tablets Market Size Markets, 2022 & 2029
        4.1.2 30mg/Piece
        4.1.3 60mg/Piece
        4.1.4 Others
    4.2 By Type - Global Nimodipine Sustained Release Tablets Revenue & Forecasts
        4.2.1 By Type - Global Nimodipine Sustained Release Tablets Revenue, 2018-2023
        4.2.2 By Type - Global Nimodipine Sustained Release Tablets Revenue, 2024-2029
        4.2.3 By Type - Global Nimodipine Sustained Release Tablets Revenue Market Share, 2018-2029
    4.3 By Type - Global Nimodipine Sustained Release Tablets Sales & Forecasts
        4.3.1 By Type - Global Nimodipine Sustained Release Tablets Sales, 2018-2023
        4.3.2 By Type - Global Nimodipine Sustained Release Tablets Sales, 2024-2029
        4.3.3 By Type - Global Nimodipine Sustained Release Tablets Sales Market Share, 2018-2029
    4.4 By Type - Global Nimodipine Sustained Release Tablets Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Nimodipine Sustained Release Tablets Market Size, 2022 & 2029
        5.1.2 Hospital
        5.1.3 Pharmacy
        5.1.4 Others
    5.2 By Application - Global Nimodipine Sustained Release Tablets Revenue & Forecasts
        5.2.1 By Application - Global Nimodipine Sustained Release Tablets Revenue, 2018-2023
        5.2.2 By Application - Global Nimodipine Sustained Release Tablets Revenue, 2024-2029
        5.2.3 By Application - Global Nimodipine Sustained Release Tablets Revenue Market Share, 2018-2029
    5.3 By Application - Global Nimodipine Sustained Release Tablets Sales & Forecasts
        5.3.1 By Application - Global Nimodipine Sustained Release Tablets Sales, 2018-2023
        5.3.2 By Application - Global Nimodipine Sustained Release Tablets Sales, 2024-2029
        5.3.3 By Application - Global Nimodipine Sustained Release Tablets Sales Market Share, 2018-2029
    5.4 By Application - Global Nimodipine Sustained Release Tablets Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
    6.1 By Region - Global Nimodipine Sustained Release Tablets Market Size, 2022 & 2029
    6.2 By Region - Global Nimodipine Sustained Release Tablets Revenue & Forecasts
        6.2.1 By Region - Global Nimodipine Sustained Release Tablets Revenue, 2018-2023
        6.2.2 By Region - Global Nimodipine Sustained Release Tablets Revenue, 2024-2029
        6.2.3 By Region - Global Nimodipine Sustained Release Tablets Revenue Market Share, 2018-2029
    6.3 By Region - Global Nimodipine Sustained Release Tablets Sales & Forecasts
        6.3.1 By Region - Global Nimodipine Sustained Release Tablets Sales, 2018-2023
        6.3.2 By Region - Global Nimodipine Sustained Release Tablets Sales, 2024-2029
        6.3.3 By Region - Global Nimodipine Sustained Release Tablets Sales Market Share, 2018-2029
    6.4 North America
        6.4.1 By Country - North America Nimodipine Sustained Release Tablets Revenue, 2018-2029
        6.4.2 By Country - North America Nimodipine Sustained Release Tablets Sales, 2018-2029
        6.4.3 US Nimodipine Sustained Release Tablets Market Size, 2018-2029
        6.4.4 Canada Nimodipine Sustained Release Tablets Market Size, 2018-2029
        6.4.5 Mexico Nimodipine Sustained Release Tablets Market Size, 2018-2029
    6.5 Europe
        6.5.1 By Country - Europe Nimodipine Sustained Release Tablets Revenue, 2018-2029
        6.5.2 By Country - Europe Nimodipine Sustained Release Tablets Sales, 2018-2029
        6.5.3 Germany Nimodipine Sustained Release Tablets Market Size, 2018-2029
        6.5.4 France Nimodipine Sustained Release Tablets Market Size, 2018-2029
        6.5.5 U.K. Nimodipine Sustained Release Tablets Market Size, 2018-2029
        6.5.6 Italy Nimodipine Sustained Release Tablets Market Size, 2018-2029
        6.5.7 Russia Nimodipine Sustained Release Tablets Market Size, 2018-2029
        6.5.8 Nordic Countries Nimodipine Sustained Release Tablets Market Size, 2018-2029
        6.5.9 Benelux Nimodipine Sustained Release Tablets Market Size, 2018-2029
    6.6 Asia
        6.6.1 By Region - Asia Nimodipine Sustained Release Tablets Revenue, 2018-2029
        6.6.2 By Region - Asia Nimodipine Sustained Release Tablets Sales, 2018-2029
        6.6.3 China Nimodipine Sustained Release Tablets Market Size, 2018-2029
        6.6.4 Japan Nimodipine Sustained Release Tablets Market Size, 2018-2029
        6.6.5 South Korea Nimodipine Sustained Release Tablets Market Size, 2018-2029
        6.6.6 Southeast Asia Nimodipine Sustained Release Tablets Market Size, 2018-2029
        6.6.7 India Nimodipine Sustained Release Tablets Market Size, 2018-2029
    6.7 South America
        6.7.1 By Country - South America Nimodipine Sustained Release Tablets Revenue, 2018-2029
        6.7.2 By Country - South America Nimodipine Sustained Release Tablets Sales, 2018-2029
        6.7.3 Brazil Nimodipine Sustained Release Tablets Market Size, 2018-2029
        6.7.4 Argentina Nimodipine Sustained Release Tablets Market Size, 2018-2029
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Nimodipine Sustained Release Tablets Revenue, 2018-2029
        6.8.2 By Country - Middle East & Africa Nimodipine Sustained Release Tablets Sales, 2018-2029
        6.8.3 Turkey Nimodipine Sustained Release Tablets Market Size, 2018-2029
        6.8.4 Israel Nimodipine Sustained Release Tablets Market Size, 2018-2029
        6.8.5 Saudi Arabia Nimodipine Sustained Release Tablets Market Size, 2018-2029
        6.8.6 UAE Nimodipine Sustained Release Tablets Market Size, 2018-2029
7 Manufacturers & Brands Profiles
    7.1 Bionpharma
        7.1.1 Bionpharma Company Summary
        7.1.2 Bionpharma Business Overview
        7.1.3 Bionpharma Nimodipine Sustained Release Tablets Major Product Offerings
        7.1.4 Bionpharma Nimodipine Sustained Release Tablets Sales and Revenue in Global (2018-2023)
        7.1.5 Bionpharma Key News & Latest Developments
    7.2 Arbor Pharmaceuticals
        7.2.1 Arbor Pharmaceuticals Company Summary
        7.2.2 Arbor Pharmaceuticals Business Overview
        7.2.3 Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Major Product Offerings
        7.2.4 Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Sales and Revenue in Global (2018-2023)
        7.2.5 Arbor Pharmaceuticals Key News & Latest Developments
    7.3 Sofgen Pharmaceuticals
        7.3.1 Sofgen Pharmaceuticals Company Summary
        7.3.2 Sofgen Pharmaceuticals Business Overview
        7.3.3 Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Major Product Offerings
        7.3.4 Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Sales and Revenue in Global (2018-2023)
        7.3.5 Sofgen Pharmaceuticals Key News & Latest Developments
    7.4 Pharmaceutics International
        7.4.1 Pharmaceutics International Company Summary
        7.4.2 Pharmaceutics International Business Overview
        7.4.3 Pharmaceutics International Nimodipine Sustained Release Tablets Major Product Offerings
        7.4.4 Pharmaceutics International Nimodipine Sustained Release Tablets Sales and Revenue in Global (2018-2023)
        7.4.5 Pharmaceutics International Key News & Latest Developments
    7.5 Heritage Pharmaceuticals
        7.5.1 Heritage Pharmaceuticals Company Summary
        7.5.2 Heritage Pharmaceuticals Business Overview
        7.5.3 Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Major Product Offerings
        7.5.4 Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Sales and Revenue in Global (2018-2023)
        7.5.5 Heritage Pharmaceuticals Key News & Latest Developments
    7.6 Bayer Vital
        7.6.1 Bayer Vital Company Summary
        7.6.2 Bayer Vital Business Overview
        7.6.3 Bayer Vital Nimodipine Sustained Release Tablets Major Product Offerings
        7.6.4 Bayer Vital Nimodipine Sustained Release Tablets Sales and Revenue in Global (2018-2023)
        7.6.5 Bayer Vital Key News & Latest Developments
    7.7 Wuhan HITECK Biopharmaceutical
        7.7.1 Wuhan HITECK Biopharmaceutical Company Summary
        7.7.2 Wuhan HITECK Biopharmaceutical Business Overview
        7.7.3 Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Major Product Offerings
        7.7.4 Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Sales and Revenue in Global (2018-2023)
        7.7.5 Wuhan HITECK Biopharmaceutical Key News & Latest Developments
    7.8 Qilu Pharmaceutical
        7.8.1 Qilu Pharmaceutical Company Summary
        7.8.2 Qilu Pharmaceutical Business Overview
        7.8.3 Qilu Pharmaceutical Nimodipine Sustained Release Tablets Major Product Offerings
        7.8.4 Qilu Pharmaceutical Nimodipine Sustained Release Tablets Sales and Revenue in Global (2018-2023)
        7.8.5 Qilu Pharmaceutical Key News & Latest Developments
    7.9 Yabao Pharmaceutical Group
        7.9.1 Yabao Pharmaceutical Group Company Summary
        7.9.2 Yabao Pharmaceutical Group Business Overview
        7.9.3 Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Major Product Offerings
        7.9.4 Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Sales and Revenue in Global (2018-2023)
        7.9.5 Yabao Pharmaceutical Group Key News & Latest Developments
    7.10 Sihuan Pharmaceutical
        7.10.1 Sihuan Pharmaceutical Company Summary
        7.10.2 Sihuan Pharmaceutical Business Overview
        7.10.3 Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Major Product Offerings
        7.10.4 Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Sales and Revenue in Global (2018-2023)
        7.10.5 Sihuan Pharmaceutical Key News & Latest Developments
    7.11 Jiangsu Kanion Pharmaceutical
        7.11.1 Jiangsu Kanion Pharmaceutical Company Summary
        7.11.2 Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Business Overview
        7.11.3 Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Major Product Offerings
        7.11.4 Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Sales and Revenue in Global (2018-2023)
        7.11.5 Jiangsu Kanion Pharmaceutical Key News & Latest Developments
    7.12 Shandong Yunmen Pharmaceutical
        7.12.1 Shandong Yunmen Pharmaceutical Company Summary
        7.12.2 Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Business Overview
        7.12.3 Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Major Product Offerings
        7.12.4 Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Sales and Revenue in Global (2018-2023)
        7.12.5 Shandong Yunmen Pharmaceutical Key News & Latest Developments
8 Global Nimodipine Sustained Release Tablets Production Capacity, Analysis
    8.1 Global Nimodipine Sustained Release Tablets Production Capacity, 2018-2029
    8.2 Nimodipine Sustained Release Tablets Production Capacity of Key Manufacturers in Global Market
    8.3 Global Nimodipine Sustained Release Tablets Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Nimodipine Sustained Release Tablets Supply Chain Analysis
    10.1 Nimodipine Sustained Release Tablets Industry Value Chain
    10.2 Nimodipine Sustained Release Tablets Upstream Market
    10.3 Nimodipine Sustained Release Tablets Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Nimodipine Sustained Release Tablets Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Nimodipine Sustained Release Tablets Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?